Post-transplant anemia and associated risk factors: the impact of steroid-free therapy

Oliveira, Claudia Maria Costa; Timbó, Paula Sátiro; Pinheiro, Sanna Roque; Leite, Janaína Gonçalves Silva; Timbó, Luciana Sátiro; Esmeraldo, Ronaldo Matos
November 2013
Sao Paulo Medical Journal;Nov2013, Vol. 131 Issue 6, p369
Academic Journal
No abstract available.


Related Articles

  • Posttransplant anemia: the role of sirolimus. Fishbane, Steven; Cohen, David J.; Coyne, Daniel W.; Djamali, Arjang; Singh, Ajay K.; Wish, Jay B. // Kidney International;Aug2009, Vol. 76 Issue 4, p376 

    Posttransplant anemia is a common problem that may hinder patients’ quality of life. It occurs in 12 to 76% of patients, and is most common in the immediate posttransplant period. A variety of factors have been identified that increase the risk of posttransplant anemia, of which the level...

  • Erythropoietin and renal transplantation. Muirhead, Norman // Kidney International Supplement;Mar1999, Issue 69, pS-86 

    Examines the impact of erythropoietin on renal transplant patients. Factors influencing the recovery of anemia following renal transplant; Iron metabolism of hemodialysis patients; Problem associated with early post-transplant period.

  • Post-Transplantation Anemia, Risk Factors Identified.  // Renal & Urology News;Aug2011, Vol. 10 Issue 8, p10 

    The article reports on findings of a study by researchers in Portugal led by professor Sophia Rocha which identified risk factors for anemia in renal post-transplant recipients.

  • Medical and economic impact of anemia in hospitalized patients. Spence, Richard K. // American Journal of Health-System Pharmacy;8/15/2007 Supplement, Vol. 64, pS3 

    Purpose. Studies indicate that the prevalence of anemia in a number of patient populations is more common than originally thought, and that more patients go untreated. Current trends in the prevalence of anemia and the consequences of untreated anemia are described. Summary. Untreated anemia is...

  • Chemotherapy-associated hematopoietic toxicity. Kuhn, John G. // American Journal of Health-System Pharmacy;8/1/2002 Supplement 4, Vol. 59, pS4 

    Discusses the strategies in managing antineoplastic therapy associated hematopoietic toxicity. Risks posed by chemotherapy-induced thrombocytopenia; Factors affecting the chemotherapy-induced anemia; Symptoms of anemia.

  • Anemia in HIV Infection: Clinical Impact and Evidence-Based Management Strategies. Volberding, Paul A.; Levine, Alexandra M.; Dieterich, Douglas; Mildvan, Donna; Mitsuyasu, Ronald; Saag, Michael // Clinical Infectious Diseases;5/15/2004, Vol. 38 Issue 10, p1454 

    Anemia in human immunodeficiency virus (HIV)-infected patients can have serious implications, which vary from functional and quality-of-life decrements to an association with disease progression and decreased survival. In 2002, 16 members of the Anemia in HIV Working Group, an expert panel of...

  • Iron deficiency anaemia and febrile convulsions: Case-control study in children under 2 years. Pisacane, Alfredo; Sansone, Renato // BMJ: British Medical Journal (International Edition);8/10/96, Vol. 313 Issue 7053, p343 

    Presents a study on the association between iron deficiency anemia and febrile convulsions. Risk factors for iron deficiency anemia; Incidence; Distribution.

  • Intravenous iron for the treatment of predialysis anemia. Silverberg, Donald S.; Blum, Miriam; Agbaria, Zodi; Schwartz, Doron; Zubkov, Alexander; Yachnin, Tatiana; Iaina, Adrian // Kidney International Supplement;Mar1999, Issue 69, pS-79 

    Examines the effects of intravenous iron on the treatment of predialysis anemia. Association of anemia with chronic renal failure; Risk associated with iron therapy; Toxicity of iron on the kidney.

  • Anemia in heart failure. Kiliçgedik, Alev; Dündar, Cihan; Tigen, Mustafa Kürşat // Anatolian Journal of Cardiology / Anadolu Kardiyoloji Dergisi;Feb2012, Vol. 12 Issue 1, p65 

    Chronic heart failure is a common problem and a major cause of death, hospital admission, poor physical function and impaired quality of life. In addition to the direct effect of heart failure on prognosis, several modifiable and non-modifiable factors contribute to the worse prognosis in heart...

  • Steroid preservation: the rationale for continued prescribing. Marks, Stephen D.; Trompeter, Richard S. // Pediatric Nephrology;Mar2006, Vol. 21 Issue 3, p305 

    Tailored immunosuppression according to risk stratification for optimal outcome for both immunological and non-immunological risk factors should be the ultimate objective for every child in whom renal transplantation is planned. Renal allograft survival is dependent on the appropriate use of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics